Solvatomorphism and first-time observation of acid-acid catemer in 4-phenylamino-benzoic acids.


Journal

RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657

Informations de publication

Date de publication:
07 Jul 2023
Historique:
received: 18 06 2023
accepted: 30 06 2023
medline: 24 7 2023
pubmed: 24 7 2023
entrez: 24 7 2023
Statut: epublish

Résumé

To investigate the polymorphism in 4-phenylamino-benzoic acids (4-PABAs) in general, and the effect on the polymorphism of these compounds exerted by substitution in particular, a series of 4-PABAs (1-8) varying in the substitution position and pattern were synthesized, and their polymorphic behavior was investigated for the first time. A relatively comprehensive polymorph screening led to the discovery of two forms, one solvent-free and the other solvate, for compounds 1, 3 and 8, and one form for the other compounds. The crystal structures were determined by single-crystal XRD. All the 4-PABAs in the crystal structures are highly twisted, and all the solvent-free crystals are based on the conventional acid-acid dimer motif, except for 2, which has a rarely observed acid-acid catemer motif. Two of the solvates (1-S and 8-S) have pyridine in the lattice while the other (3-S) has dichloromethane. The observation indicates that neither conformational flexibility or substitution alone nor the combination of both leads to polymorphism in these compounds, which is in dramatic contrast to the polymorphism of fenamic acids. The thermal properties of each system were investigated by differential scanning calorimetry and desolvation of the solvates was studied by thermogravimetric analysis. Hirshfeld surface analysis and molecular dynamics simulation were performed to study the mechanism of polymorphism and the intermolecular interactions contributing to the formation and stability of each crystal form.

Identifiants

pubmed: 37484866
doi: 10.1039/d3ra04102f
pii: d3ra04102f
pmc: PMC10357492
doi:

Types de publication

Journal Article

Langues

eng

Pagination

21021-21035

Informations de copyright

This journal is © The Royal Society of Chemistry.

Déclaration de conflit d'intérêts

There are no conflicts of interest to declare.

Références

Chem Commun (Camb). 2009 Jun 14;(22):3199-201
pubmed: 19587912
J Org Chem. 2006 Apr 14;71(8):3270-3
pubmed: 16599627
Cryst Growth Des. 2008;8(1):136-139
pubmed: 19367341
Curr Med Res Opin. 1977;4(8):535-9
pubmed: 326491
J Am Chem Soc. 2012 Jun 20;134(24):9872-5
pubmed: 22690822
J Chem Phys. 2020 Sep 21;153(11):114502
pubmed: 32962378
Bioorg Med Chem. 2016 Mar 1;24(5):929-37
pubmed: 26810709
J Med Chem. 2012 Mar 8;55(5):2311-23
pubmed: 22263837
J Pharm Sci. 2010 Feb;99(2):794-803
pubmed: 19603503
J Neuroinflammation. 2019 Oct 10;16(1):186
pubmed: 31601232
Bioorg Med Chem Lett. 2009 Feb 1;19(3):654-7
pubmed: 19121939
Scand J Rheumatol Suppl. 1979;(24):5-7
pubmed: 373085
Chem Commun (Camb). 2015 Feb 11;51(12):2245-8
pubmed: 25514992
J Comput Chem. 2002 Dec;23(16):1623-41
pubmed: 12395429
J Nippon Med Sch. 2002 Jun;69(3):224-34
pubmed: 12068313
J Inorg Biochem. 2009 May;103(5):738-44
pubmed: 19237201
J Gen Virol. 1969 Mar;4(2):203-14
pubmed: 4306296
J Pharm Biomed Anal. 2020 Feb 20;180:113058
pubmed: 31881398
Bioorg Med Chem Lett. 2011 Mar 1;21(5):1464-8
pubmed: 21277203
Bioorg Med Chem Lett. 2007 Jun 1;17(11):3113-6
pubmed: 17400450
Curr Med Res Opin. 1977;5(2):189-91
pubmed: 340138
Acta Crystallogr C Struct Chem. 2015 Jan;71(Pt 1):3-8
pubmed: 25567568
Drugs. 1986;32 Suppl 4:27-45
pubmed: 3552584
Chem Biol Drug Des. 2015 Aug;86(2):223-31
pubmed: 25430863
J Pharmacol Exp Ther. 1998 Oct;287(1):208-13
pubmed: 9765339

Auteurs

Xiaoting Liu (X)

Key Laboratory for Green Chemical Process of Ministry of Education, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, Hubei Engineering Research Center for Advanced Fine Chemicals, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology 206 1st Rd Optics Valley, East Lake New Technology Development District Wuhan Hubei 430205 China sihuilong@wit.edu.cn 1783054890@qq.com +86 027 87194980.

Jingliang Cui (J)

Key Laboratory for Green Chemical Process of Ministry of Education, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, Hubei Engineering Research Center for Advanced Fine Chemicals, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology 206 1st Rd Optics Valley, East Lake New Technology Development District Wuhan Hubei 430205 China sihuilong@wit.edu.cn 1783054890@qq.com +86 027 87194980.

Qun Zeng (Q)

XtalPi Inc The 3rd Floor of the Second Phase of the International Biomedical Industrial Park, No. 2 Hongliu Road, Futian District Shenzhen 518000 China.

Liwen Fang (L)

XtalPi Inc The 3rd Floor of the Second Phase of the International Biomedical Industrial Park, No. 2 Hongliu Road, Futian District Shenzhen 518000 China.

Peng-Yu Liang (PY)

College of Chemistry and Chemical Engineering, Lanzhou University Lanzhou 730000 China zhoupp@lzu.edu.cn.

Pan-Pan Zhou (PP)

College of Chemistry and Chemical Engineering, Lanzhou University Lanzhou 730000 China zhoupp@lzu.edu.cn.

Sean Parkin (S)

Department of Chemistry, University of Kentucky Lexington Kentucky 40506 USA.

Tonglei Li (T)

Department of Industrial and Physical Pharmacy, Purdue University West Lafayette Indiana 47907 USA.

Shigang Ruan (S)

XtalPi Inc The 3rd Floor of the Second Phase of the International Biomedical Industrial Park, No. 2 Hongliu Road, Futian District Shenzhen 518000 China.

Sihui Long (S)

Key Laboratory for Green Chemical Process of Ministry of Education, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, Hubei Engineering Research Center for Advanced Fine Chemicals, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology 206 1st Rd Optics Valley, East Lake New Technology Development District Wuhan Hubei 430205 China sihuilong@wit.edu.cn 1783054890@qq.com +86 027 87194980.

Classifications MeSH